Duarte Pignatelli
Sort By:
Year:
Note: This data was collect using the ISI Web of Science database.
 
Legend:
C - Citations
IF - Impact Factor
(*) Last Impact Factor reported
 
 
C
IF
1. Pitteloud N, Zhang C, Pignatelli D, Li JD, Raivio T, Cole LW, Plummer L, Jacobson-Dickman EE, Mellon PL, Zhou QY, Crowley WF
Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proceedings of the National Academy of Sciences of the United States of America 104: 17447-52, 2007.  [Article] 
 
2. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley WF, Zhou QY, Pitteloud N
 
3. Pereira SS, Costa MM, Gomez-Sanchez CE, Monteiro MP, Pignatelli D
 
4. Pereira SS, Monteiro MP, Bourdeau I, Lacroix A, Pignatelli D
MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma. European journal of endocrinology 179: R95-R110, 2018.  [Review] 
 doi: 10.1530/EJE-17-0976 PMID: 29773584.
 
5. Pereira SS, Monteiro MP, Costa MM, Ferreira J, Alves MG, Oliveira PF, Jarak I, Pignatelli D
MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors. Journal of cellular biochemistry 120: 894-906, 2019.  [Article] 
 doi: 10.1002/jcb.27451 PMID: 30256438.
 
6. Pignatelli D, Carvalho BL, Palmeiro A, Barros A, Guerreiro SG, Maçut D
 
7. Pignatelli D, Carvalho BL, Palmeiro A, Barros A, Guerreiro SG, Macut D
 
8. Rodrigues AR, Pignatelli D, Almeida H, Gouveia AM
Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Molecular and cellular endocrinology 303: 74-81, 2009.  [Article] 
 
9. Pereira SS, Monteiro MP, Costa MM, Moreira Â, Alves MG, Oliveira PF, Jarak I, Pignatelli D
IGF2 role in adrenocortical carcinoma biology. Endocrine 66: 326-337, 2019.  [Article] 
 
10. Crespigio J, Berbel LCL, Dias MA, Berbel RF, Pereira SS, Pignatelli D, Mazzuco TL
Von Hippel-Lindau disease: a single gene, several hereditary tumors. Journal of endocrinological investigation 41: 21-31, 2018.  [Review] 
 
11. Pall M, Azziz R, Beires J, Pignatelli D
 
12. Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas. Journal of cellular biochemistry 118: 2064-2071, 2017.  [Article] 
 doi: 10.1002/jcb.25811 PMID: 27886397.
 
13. Ferreira JG, Cruz CD, Neves D, Pignatelli D
 doi: 10.1677/joe.1.06961 PMID: 17332532.
 
14. Pereira SS, Monteiro MP, Antonini SR, Pignatelli D
Apoptosis regulation in adrenocortical carcinoma. Endocrine connections 8: R91-R104, 2019.  [Review] 
 doi: 10.1530/EC-19-0114 PMID: 30978697.
 
15. Pignatelli D, Ferreira J, Soares P, Costa MJ, Magalhães MC
 doi: 10.1002/jemt.10341 PMID: 12768547.
 
16. Pereira SS, Costa MM, Guerreiro SG, Monteiro MP, Pignatelli D
Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors. Pathology oncology research : POR 24: 689-693, 2018.  [Article] 
 
17. Marques CJ, Pignatelli D, Carvalho B, Barceló J, Almeida AC, Fernandes S, Witchel SF, Sousa M, Oliveira MJ, Freitas P, Fontoura M, Carvalho D, Barros A, Carvalho F
Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 118: 505-12, 2010.  [Article] 
 
Send Email
From
To
Subject